AI assistant
Elbit Imaging-M Ltd. Delisting Announcement 2019
6760_rns_2019-05-05_e1293cf3-e8b0-40c3-b210-3a7aa00661cc.pdf
Delisting Announcement
Open in viewerOpens in your device viewer
ELBIT IMAGING ANNOUNCES DELISTING OF ITS ORDINARY SHARES ON NASDAQ EFFECTIVE FROM MAY 13, 2019
Tel Aviv, Israel, May 5, 2019, Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to its press release dated February 7, 2019, that the NASDAQ Stock Market (the "Nasdaq") has filed a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the "SEC") after applicable appeal periods have lapsed to notify the SEC of the delisting of the Company's ordinary shares.
The Nasdaq has determined to remove from listing the ordinary shares of the Company, effective at the opening of the trading session on May 13, 2019.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of business: (i) medical industries through our indirect holdings in Insightec Ltd. and Gamida Cell Ltd.; and (ii) land in India which is designated for sale (and which was initially designated for residential projects).
For Further Information: Company Contact Ron Hadassi CEO and Chairman of the Board of Directors Tel: +972-3-608-6048 Fax: +972-3-608-6050 [email protected]